GeoVax Labs, Inc. Logo

GeoVax Labs, Inc.

Clinical-stage biotech developing vaccines and therapies for infectious diseases and cancer.

GOVX | US

Overview

Corporate Details

ISIN(s):
US3736786068
LEI:
Country:
United States of America
Address:
1900 LAKE PARK DRIVE, 30080 SMYRNA

Description

GeoVax Labs, Inc. is a clinical-stage biotechnology company that develops human vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms. The company's lead oncology program is Gedeptin®, a therapy for advanced head and neck cancers which has completed enrollment in a Phase 1/2 clinical trial. Its primary infectious disease candidate is GEO-CM04S1, a next-generation COVID-19 vaccine being evaluated in Phase 2 clinical trials for high-risk, immunocompromised populations and as a heterologous booster. GeoVax's development pipeline also includes research programs for preventive vaccines against Mpox, smallpox, hemorrhagic fever viruses such as Ebola and Marburg, malaria, and Zika virus, alongside therapies for various solid tumors.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-06 15:49
FORM 4
English 7.1 KB
2025-06-06 15:48
FORM 4
English 7.1 KB
2025-06-06 15:46
FORM 4
English 7.1 KB
2025-06-06 15:45
FORM 4
English 7.0 KB
2025-06-06 15:42
FORM 4
English 7.2 KB
2025-06-06 15:41
FORM 4
English 7.2 KB
2025-06-06 15:39
FORM 4
English 7.2 KB
2025-06-06 15:38
FORM 4
English 7.2 KB
2025-06-06 15:35
FORM 4
English 7.2 KB
2025-06-05 22:40
FORM 8-K
English 62.9 KB
2025-06-02 22:05 English 68.5 KB
2025-06-02 22:04 English 464.2 KB
2025-05-15 21:15 English 9.9 KB
2025-05-01 23:08
FORM 424B3
English 69.3 KB
2025-05-01 23:06
FORM 424B3
English 69.3 KB

Automate Your Workflow. Get a real-time feed of all GeoVax Labs, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GeoVax Labs, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GeoVax Labs, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.